Shock, Septic: all 890 studies

Page 2 of 9. Open to participants first (210), then studies with results posted, then the rest; newest registration first within each.

• Shenfu Injection Modulates Carotid Elasticity in Septic ShockNot yet recruitingNCT06915506Phase 4
• Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill PatientsEnrolling by invitationNCT06904001
• The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in SepsisRecruitingNCT06898723Phase 4
• Prognostic Value of Right Ventricular-pulmonary Arterial Coupling Assessed by Echocardiography in Septic PatientsRecruitingNCT06887140
• Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory FailureRecruitingNCT06881927Phase 4
• Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic ShockNot yet recruitingNCT06853574Not applicable
• Impact of Vascular Calcification and CASR Expression by Monocytes in Septic ShockRecruitingNCT06853340Not applicable
• Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled TrialNot yet recruitingNCT06851078Phase 3
• Atrial Strain in Septic ShockRecruitingNCT06832436
• Role of Transposable Elements in Septic Immune AgingRecruitingNCT06809868
• Can Gdf-15 Level Predict Progression to Multiple Organ Failure in Patients With Septic ShockEnrolling by invitationNCT06808100
• Types of Photoplethysmographic Waves in Adult Patients with Septic ShockRecruitingNCT06786364
• Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsisRecruitingNCT06766461Phase 4
• Doppler Echocardiography Versus Clinical Targets Guided Therapy on the Outcome of Postpartum Septic Shock.Not yet recruitingNCT06757985Not applicable
• Evaluation of Blood Protein O-GlcNAcylation Levels in ChildrenRecruitingNCT06754696
• Study on the Improvement of Microcirculation in Patients With Sepsis by Vitamin B6, Vitamin B12 and Vitamin CRecruitingNCT06749756Not applicable
• Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic ShockNot yet recruitingNCT06746753Phase 4
• Early Versus Late Adjunctive Vasopressin in Septic ShockRecruitingNCT06709573Phase 4
• Venous Excess Ultrasound for Personalized Resuscitation in Septic ShockNot yet recruitingNCT06696391Phase 3
• Early Angiotensin II in the Emergency DepartmentRecruitingNCT06693726Phase 4
• Adaptive Blood Purification for the Treatment of Patients With Septic ShockEnrolling by invitationNCT06692036Not applicable
• Predicts Mortality by AST/ALT Ration in Patients with Sepsis and Septic Shock During ICU AdmissinNot yet recruitingNCT06683794
• Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled TrialRecruitingNCT06670963Phase 4
• Impact of the Introduction of a Performance Improvement Program on the Initial Management of Sepsis and Septic Shock in Adults in the Emergency Department: a Before-and-after Study (IPA-SOS)Enrolling by invitationNCT06657625
• Study SOLACE SEPSISRecruitingNCT06634069Phase 2
• Significance of Disseminated Intravascular Coagulation Score in Mortality for Children With ShockNot yet recruitingNCT06581172
• Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic ShockRecruitingNCT06572995
• The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill PatientsRecruitingNCT06570187Phase 4
• Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock ResuscitationRecruitingNCT06568744Not applicable
• Renin Levels as Prognostic Indicators of Septic Shock Severity and OutcomeRecruitingNCT06545838
• Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II.RecruitingNCT06539234
• Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood SamplesNot yet recruitingNCT06531031
• The Relation Between Triglyceride- Glucose Index, Procalcitonin and Cardiac Affection in Septic Shock.Not yet recruitingNCT06518083
• OXiris for Abdominal SEptic Shock (OASES Study)Not yet recruitingNCT06504316Not applicable
• Metabolic Cluster Analysis in Septic Shock PatientsRecruitingNCT06500156
• Evaluation of the Association Between Right Atrial Reservoir Strain Variation and Fluid Responsiveness in Patients With Septic ShockRecruitingNCT06492044Not applicable
• Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic ShockRecruitingNCT06481410Not applicable
• Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic ShockRecruitingNCT06471231Phase 4
• Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent SepsisRecruitingNCT06464510Phase 3
• Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic AnalysisRecruitingNCT06446947
• Effect of Early Administration of Albumin 20% Versus CrystalloidRecruitingNCT06370078Not applicable
• UK ANDROMEDA-Shock-2 RCTNot yet recruitingNCT06366854Not applicable
• Intravenous Methylene Blue for Treating Refractory Neonatal Septic ShockNot yet recruitingNCT06306001Phase 2/3
• Dexmedetomidine and Vasopressin in Septic ShockNot yet recruitingNCT06302998Phase 2
• Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in SepsisRecruitingNCT06287684
• First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced ImmunosuppressionNot yet recruitingNCT06258291Not applicable
• The Effect of Vasopressor Therapy on Renal Perfusion in Septic ShockRecruitingNCT06234592Not applicable
• Vexus-guided Fluid Management in Patients With Septic Shock After the Resuscitation PhaseNot yet recruitingNCT06227702Not applicable
• Aminoglycoside Administration in Septic PatientsRecruitingNCT06226441Not applicable
• Xanthohumol as an Adjuvant in the Treatment of Septic ShockRecruitingNCT06225258Phase 2
• Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With SepsisRecruitingNCT06184659Phase 4
• Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency RoomRecruitingNCT06178822
• Ultrasound-guided Blood Sampling Drawing for Microbiological Analysis in the Critically IllNot yet recruitingNCT06156072
• Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic ShockRecruitingNCT06145828
• Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock PatientsRecruitingNCT06140147Not applicable
• Prodromes of Menstrual Staphylococcal Toxic ShockRecruitingNCT06124599
• Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic ShockRecruitingNCT06122987Phase 4
• CO2 Gap Changes Versus Inferior Vena Cava Collapsibility in Relation to Cardiac Index as a Prognostic Value in Septic ShockRecruitingNCT06119815Not applicable
• Evaluating Dynamic Arterial Elastance in Septic Shock Patients.Not yet recruitingNCT06118775Not applicable
• A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)RecruitingNCT06072430Phase 3
• Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2RecruitingNCT06062303Not applicable
• Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCTNot yet recruitingNCT06022445
• We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury.RecruitingNCT06001294
• Pituitary Function After Recovery From Septic Shock Among ICU SurvivorsRecruitingNCT05990491
• Reducing Empiric VAncomycin Use in Pediatric Suspected SepsisRecruitingNCT05975671Not applicable
• Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic ShockRecruitingNCT05969275Phase 2
• Early Initiated Vasopressor Therapy in the Emergency DepartmentRecruitingNCT05931601Phase 3
• Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.RecruitingNCT05928767
• Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic ShockNot yet recruitingNCT05921825
• Adjunctive Esketamine for Analgesia in Mechanically Ventilated Septic Shock PatientsRecruitingNCT05839366Phase 3
• Early Versus Conventional Cessation of Hydrocortisone in Septic ShockRecruitingNCT05818826Phase 2
• Cardiovascular Effects of NorepinephrineRecruitingNCT05761522
• Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic ShockRecruitingNCT05726825Not applicable
• Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and ImmunosuppressionRecruitingNCT05688774
• Early Severe Illness TrAnslational BioLogy InformaticS in HumansRecruitingNCT05591924
• Restricted or Liberal Fluid for Haemodynamic Resuscitation in SepsisNot yet recruitingNCT05453565
• Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient OutcomeRecruitingNCT05383963
• Lactate Kinetics in Septic ShockRecruitingNCT05349370Not applicable
• Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICURecruitingNCT05225402
• eMESH Struct. 2022-23RecruitingNCT05202938
• ExtraCorporeal Membrane Oxygenation in the Therapy for REfractory Septic Shock With Cardiac Function Under EstimatedRecruitingNCT05184296Not applicable
• Albumin and Crystalloid Administration in Septic ShockRecruitingNCT05148286Phase 4
• CytOSorb TreatMent Of Critically Ill PatientS RegistryRecruitingNCT05146336
• Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic PatientsRecruitingNCT05143736
• Therapeutic Plasma Exchange in Septic Shock: A Pilot StudyRecruitingNCT05093075Phase 2
• Safety and Efficacy of HA380 Hemoadsorption in Patients With Septic ShockRecruitingNCT04997421Not applicable
• Blood Purification in Patients With Septic ShockRecruitingNCT04957316Not applicable
• "Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"Not yet recruitingNCT04934943
• LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)RecruitingNCT04931225Phase 3
• Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care MedicineRecruitingNCT04910841Not applicable
• External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock PatientsRecruitingNCT04855786Not applicable
• Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled TrialRecruitingNCT04844801Not applicable
• Management of Shock in Children With SAM or Severe Underweight and DiarrheaRecruitingNCT04750070Phase 3
• Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With HypercontractilityRecruitingNCT04748796Phase 3
• ICITRU : Randomized Trial of Immunonutrition With L-citrulline in Patients Hospitalized in Intensive Care for Sepsis or Septic ShockRecruitingNCT04513288Not applicable
• Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic ShockRecruitingNCT04494074Not applicable
• Immune Homeostasis in Sepsis and Septic ShockRecruitingNCT04448951
• Terlipressin for Refractory Septic ShockRecruitingNCT04339868Phase 2
• Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical StudyRecruitingNCT04288635
• Sepsis: From Syndrome to Personalized CareRecruitingNCT04203979

← Shock, Septic overview